• Pomalyst Combo Delays Disease Progression in Relapsed or Refractory Myeloma Patients in Phase 3 Trial
  • PT-112 Receives Orphan Drug Status for Advanced Multiple Myeloma
  • Most Canadians Wouldn’t Know Where to Turn If Diagnosed With Blood Cancer, Survey Finds
  • Multiple Myeloma Patients in UK Gain Access to Ninlaro through Cancer Drugs Fund
  • Stem Cell Transplants Better Than New Therapies at Delaying Myeloma Progression, Analysis Finds
  • Ethyol Pretreatment Reduces Gastrointestinal Side Effects of Bone Marrow Transplant in Myeloma Patients
  • Myeloma Research Foundation and Karyopharm Hoping Myeloma Therapy Progress Continues
  • Nanoparticle-targeted Phototherapy Tested in Mice; Might Be Multiple Myeloma Therapy Someday
  • Selinexor, Dexamethasone Combo Shows Promise in Heavily Treated Myeloma Patients
  • CRISPR Gene Editing Technique Featured in Upcoming Myeloma Immunotherapy Trial
  • FDA to Give Priority Review to Darzalex Combinations for Multiple Myeloma
  • Researchers Find Faster, Better Approach to Harvesting Stem Cells for Bone Marrow Transplants, Mouse Study Suggests